Previous Page  40 / 42 Next Page
Information
Show Menu
Previous Page 40 / 42 Next Page
Page Background

Page 70

Notes:

conferenceseries

.com

Volume 7, Issue 3 (Suppl)

J Gastrointest Dig Syst, an open access journal

ISSN: 2161-069X

Gastro 2017

June 12-13, 2017

June 12-13, 2017 Rome, Italy

11

th

Global

GastroenterologistsMeeting

Comparison of the performance of LTBI screening to the BTS standards

Shuaib Meghji

University Hospital Southampton, UK

Background

: Patients with severe Inflammatory Bowel Disease (IBD) are prescribed anti-TNF-α agents, if clinical need necessitates,

whose immunosuppressive action can potentially reactivate latent tuberculosis infections (LTBI). Meticulous pre anti-TNF-α LTBI

screening and management in accordance with the British Thoracic Society’s (BTS) Guidelines is imperative for patient safety and

public health.

Objective

: A retrospective clinical audit was performed to evaluate the performance of University Hospital Southampton’s

Gastroenterology department in screening for LTBI in patients with IBD. The performance of LTBI screening was compared to the

BTS standards.

Method

: The audit population was obtained using the gastroenterology department’s biologics database. Inclusion criteria included

patients who started their first anti-TNF-α agent between 01/01/2006 to 04/11/2016. Exclusion criteria included deceased patients

and patients screened by alternative departments/trusts. Extent of LTBI screening was assessed using hospital record systems: EDocs,

EQuest, ECamis and Spectra PACS. If evidence of screening was not located, then this was considered as a failure to meet standard.

Following statistical analysis, comparisons were made with BTS standards.

Results

: Of the 471 patients audited, 51.2% were females and 48.8% males. 75.2% were CD patients and 24.8% were UC patients. 231

patients’ (49%) LTBI screening was insufficient. 157 patients (33.3%) lacked an adequate TB history and 94 patients (20%) failed to

have a chest radiograph (CXR) within three months of therapy commencement. Additionally, 85 patients (18.3%) failed to have an

IGRA performed. 15 patients (3.2%) were diagnosed with LTBI, while one case of TB reactivation occurred once immunosuppressive

therapy had commenced.

Conclusion

: The completeness of LTBI screening in the audited group was suboptimal with deficits in TB history performance, CXR,

TST and IGRAs. One case of active miliary TB occurred as a result of inadequate screening. In light of this, recommendations to

address deficits and ultimately improve screening were proposed.

Biography

Shuaib Meghji is currently studying at University Hospital Southampton, UK.

shuaibmeghji94@gmail.com

Shuaib Meghji, J Gastrointest Dig Syst 2017, 7:3(Suppl)

DOI: 10.4172/2161-069X-C1-049